See how your
product gets paid.
Price and launch
with confidence.
Market Access Analytics
Understand how your product is actually reimbursed
See how your therapy (or a competitor's) is paid across the payer landscape. Ground your pricing and total treatment costs in real negotiated rates, not assumptions.
- Payer reimbursement by geography — see variation across regions and sites of care
- Competitive rate benchmarking — see how your therapy compares to alternatives
- Coverage and access context — identify where access gaps exist—and where they don't
J-code 9999X · 5 commercial payers · 6 markets
Patient Affordability & Hub Design
Design support programs based on real coverage
Build copay and patient assistance programs using actual patient responsibility and plan allowed amounts, so support aligns with how coverage works in practice.
- Patient responsibility benchmarking — by payer, geography, and plan type
- Plan allowed amount analysis — understand what coverage actually pays
- Program gap identification — find where patients face the highest financial burden
Keytruda (pembrolizumab), HCPCS code J9271 - 4 markets
Gross-to-Net Optimization
Improve forecast accuracy with real rate data
Sharpen commercial forecasts by understanding how negotiated rates compare to list price across your target payer mix.
- Plan-allowed vs. WAC or ASP pricing analysis — quantify gaps across payers
- Rebate exposure modeling — refine gross-to-net assumptions with market data
- Outlier contract identification — identify pricing pressure before it impacts net revenue
Net Revenue Modeling: Average Sales Price (ASP) vs. Provider Reimbursement
Don't take our word for it
Here's what the teams depending on Serif every day have to say.
Used by 200+ organizations across providers, payers, and benefits.
Used by 200+ organizations across providers, payers, and benefits.
See how your product is reimbursed in the market
Understand payer behavior, benchmark your pricing by provider, and identify where you have risk—or opportunity.